Lozol: Effective Hypertension and Edema Management

Lozol

Lozol

Price from 37.84 $
Product dosage: 1.5mg
Package (num)Per pillPriceBuy
30$1.26$37.84 (0%)🛒 Add to cart
60$0.87$75.68 $52.46 (31%)🛒 Add to cart
90$0.75$113.52 $67.94 (40%)🛒 Add to cart
120$0.69$151.36 $82.56 (45%)🛒 Add to cart
180$0.63$227.04 $112.66 (50%)🛒 Add to cart
270$0.58$340.56 $157.38 (54%)🛒 Add to cart
360
$0.56 Best per pill
$454.08 $202.10 (55%)🛒 Add to cart
Product dosage: 2.5mg
Package (num)Per pillPriceBuy
30$1.83$55.04 (0%)🛒 Add to cart
60$1.30$110.08 $78.26 (29%)🛒 Add to cart
90$1.12$165.12 $100.62 (39%)🛒 Add to cart
120$1.02$220.16 $122.98 (44%)🛒 Add to cart
180$0.94$330.24 $168.56 (49%)🛒 Add to cart
270$0.88$495.36 $236.50 (52%)🛒 Add to cart
360
$0.85 Best per pill
$660.48 $304.44 (54%)🛒 Add to cart

Lozol (indapamide) is a thiazide-like diuretic medication prescribed for the management of hypertension (high blood pressure) and edema associated with congestive heart failure. By promoting the excretion of excess salt and water from the body, it effectively reduces blood volume and peripheral vascular resistance, leading to a significant and sustained reduction in blood pressure. Its once-daily dosing and favorable metabolic profile make it a cornerstone therapy in cardiovascular risk management, helping to protect target organs and reduce the long-term complications associated with uncontrolled hypertension.

Features

  • Active ingredient: Indapamide 1.25 mg or 2.5 mg
  • Pharmacological class: Thiazide-like diuretic/sulfonamide
  • Administration: Oral tablet
  • Standard dosing: Once daily
  • Onset of diuretic action: Within 1-2 hours
  • Duration of antihypertensive effect: Up to 24 hours
  • Bioavailability: Approximately 93%
  • Protein binding: 79%
  • Metabolism: Hepatic
  • Elimination: Primarily renal (60-70%) and fecal (20-30%)
  • Half-life: 14-18 hours

Benefits

  • Provides effective and sustained 24-hour blood pressure control with a single daily dose, supporting adherence to treatment.
  • Reduces edema and fluid overload in patients with congestive heart failure, alleviating symptoms like shortness of breath and swelling.
  • Demonstrates a lower risk of hypokalemia (low potassium levels) compared to some conventional thiazide diuretics when used at standard doses.
  • Has been shown to reduce left ventricular hypertrophy, an independent risk factor for cardiovascular events.
  • May offer pleiotropic effects, including vasodilation and some calcium channel blocking activity, contributing to its antihypertensive efficacy.
  • Helps lower the risk of stroke, myocardial infarction, and other cardiovascular complications associated with long-term hypertension.

Common use

Lozol is primarily indicated for the first-line treatment of essential hypertension, either as monotherapy or in combination with other antihypertensive agents such as ACE inhibitors, angiotensin II receptor blockers, or beta-blockers. It is also effectively used to manage edema (fluid retention) resulting from congestive heart failure. In clinical practice, it is often selected for patients who require a gentle diuretic effect or for those in whom metabolic side effects like significant potassium loss are a concern. Its use is grounded in major hypertension management guidelines worldwide.

Dosage and direction

The recommended dosage for hypertension is 1.25 mg once daily, taken in the morning. This dose may be increased to 2.5 mg once daily if the blood pressure response is inadequate after 4 weeks of therapy. For the management of edema, the typical dose is 2.5 mg once daily in the morning. The tablet should be swallowed whole with a glass of water, and can be taken with or without food. Consistent daily timing is recommended to maintain stable drug levels. Dosage adjustments are necessary in patients with severe renal impairment (creatinine clearance < 30 mL/min), as the drug may be less effective and the risk of adverse effects increases. Hepatic impairment also warrants caution and potential dose reduction.

Precautions

Patients should be advised that Lozol may cause dizziness or lightheadedness, especially during the initial phase of therapy or after a dosage increase; caution is advised when driving or operating machinery. Regular monitoring of serum electrolytes (particularly potassium, sodium, magnesium, and calcium), blood glucose, uric acid, creatinine, and BUN is recommended, especially in the elderly, those with pre-existing electrolyte imbalances, or patients on concomitant medications that affect electrolytes. Adequate hydration should be maintained, but excessive fluid intake is not necessary. Patients with a history of gout may experience exacerbations due to increased uric acid levels. Photosensitivity reactions have been reported; use of sunscreen and protective clothing is advisable.

Contraindications

Lozol is contraindicated in patients with a known hypersensitivity to indapamide, other sulfonamide-derived drugs, or any component of the formulation. It must not be used in patients with severe renal impairment (anuria), or in those with hepatic encephalopathy or severe liver dysfunction. Use is also contraindicated in cases of pre-existing significant hypokalemia or hyponatremia that cannot be corrected. The drug is not recommended during breastfeeding.

Possible side effect

Common side effects (may affect up to 1 in 10 users) include headache, dizziness, fatigue, and muscle cramps or weakness (often related to electrolyte disturbances). Gastrointestinal effects such as nausea, constipation, or dry mouth may occur. Less frequently, orthostatic hypotension, palpitations, rash, pruritus, and increased sensitivity to sunlight (photosensitivity) are observed. Laboratory abnormalities can include hypokalemia, hyponatremia, hypochloremia, hypercalcemia, hyperglycemia (especially in diabetic patients), and increased uric acid levels. Rare but serious side effects include severe electrolyte imbalances leading to arrhythmias, pancreatitis, and blood dyscrasias such as leukopenia or thrombocytopenia.

Drug interaction

Lozol can interact with several classes of medications. Concomitant use with other antihypertensive agents may lead to an additive hypotensive effect. It can potentiate the effects of neuromuscular blocking agents like tubocurarine. Corticosteroids, ACTH, amphotericin B, and stimulant laxatives may increase the risk of hypokalemia. NSAIDs (e.g., ibuprofen, naproxen) can reduce the antihypertensive and diuretic efficacy of indapamide. Lithium levels may increase, risking toxicity, requiring close monitoring. The hypokalemic effect may increase the risk of digoxin toxicity. Alcohol, barbiturates, or narcotics may potentiate orthostatic hypotension.

Missed dose

If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped. Doubling the dose to make up for a missed one is not recommended, as it may increase the risk of side effects such as hypotension or electrolyte disturbances. Patients should be advised to maintain a consistent dosing schedule to ensure stable blood pressure control.

Overdose

Symptoms of overdose primarily relate to excessive pharmacologic effects: profound water and electrolyte depletion (manifesting as weakness, dizziness, drowsiness, confusion, nausea, vomiting, and muscle cramps or weakness) and severe hypotension, which may lead to circulatory collapse. Bradycardia and cardiac arrhythmias secondary to hypokalemia can occur. Gastric lavage and/or activated charcoal may be considered if ingestion was recent. Treatment is supportive and symptomatic, focusing on fluid and electrolyte replacement (particularly potassium and sodium) and cardiovascular support. There is no specific antidote. Hemodialysis is not effective due to high protein binding.

Storage

Store Lozol tablets at room temperature, between 15°C and 30°C (59°F and 86°F), in a dry place protected from light and moisture. Keep the medication in its original container, tightly closed, and out of the reach of children and pets. Do not store in bathrooms or near sinks. Do not use tablets that are beyond the expiration date printed on the packaging, or that show signs of deterioration such as discoloration or crumbling.

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content provided is based on general prescribing information and may not cover all possible uses, directions, precautions, or interactions specific to your individual health status.

Reviews

Clinical studies and meta-analyses consistently demonstrate that indapamide (Lozol) provides effective and sustained 24-hour blood pressure reduction. Its metabolic profile, particularly a lower risk of hypokalemia compared to hydrochlorothiazide at equipotent doses, is frequently cited as a significant advantage in long-term management. It is well-regarded in guidelines such as those from the ESC/ESH for its efficacy in reducing cardiovascular events, especially stroke. Patient reviews often note effective blood pressure control with once-daily convenience, though some report initial dizziness or muscle cramps. It is considered a valuable option in the antihypertensive arsenal, particularly for patients requiring a gentle diuretic effect.